0001104659-24-010796.txt : 20240205
0001104659-24-010796.hdr.sgml : 20240205
20240205185309
ACCESSION NUMBER: 0001104659-24-010796
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cramer Pamela J.
CENTRAL INDEX KEY: 0001873517
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38223
FILM NUMBER: 24597446
MAIL ADDRESS:
STREET 1: C/O RHYTHM PHARMACEUTICALS
STREET 2: 222 BERKELEY STREET, SUITE 1200
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001649904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 462159271
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 857-264-4280
MAIL ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: RHYTHM METABOLIC, INC.
DATE OF NAME CHANGE: 20150803
4
1
tm245251-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-01
0
0001649904
RHYTHM PHARMACEUTICALS, INC.
RYTM
0001873517
Cramer Pamela J.
C/O RHYTHM PHARMACEUTICALS, INC.
222 BERKELEY STREET, 12TH FLOOR
BOSTON
MA
02116
0
1
0
0
Chief Human Resources Officer
0
Common Stock
2024-02-01
4
M
0
2650
A
11068
D
Common Stock
2024-02-01
4
S
0
946
45.06
D
10122
D
Restricted Stock Units
2024-02-01
4
M
0
2650
0
D
Common Stock
2650
7950
D
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
The restricted stock units vest or have vested as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date.
/s/ Hunter Smith, attorney-in-fact for Pamela J. Cramer
2024-02-05